New Clinical Study yekurapa mamota echiropa

ABK Biomedical, Inc. yakazivisa murwere wekutanga kurapwa muABK Yekutanga-mu-Munhu kudzidza neEye90 microspheres™, Y90 radioembolization mudziyo wekurapwa kwegomarara rechiropa. Ongororo iyi iri kuitwa pamwe chete neAuckland Hospital Research Unit, New Zealand.              

Iyo inotarisirwa, imwe-center, yakavhurika-label kudzidza iri kuongorora kuchengetedzwa uye kushanda kweEye90 microspheres kune varwere vane unresectable hepatocellular carcinoma (HCC) kana metastatic colorectal cancer (mCRC). Varwere vanogashira imwe Eye90 microspheres radioembolization kurapwa nekutevera kushanya kwegore rimwe kuongorora kuchengetedzwa, kushanda, uye mhando yehupenyu matanho.

Eye90 microspheres iradiopaque glass microspheres inoonekwa pa x-ray uye Computed Tomography (CT) imaging uye ine Yttrium 90 (Y90) radiotherapeutic element. Y90 radioembolization, brachytherapy yemuno, parizvino inoshandiswa kurapa mamota akaipa echiropa. Gomarara rekutanga rechiropa ndiro rechitanhatu rinonyanya kubatwa gomarara uye rechitatu rinotungamira kufa kwegomarara pasi rose, paine zviitiko zvitsva zvinosvika 906,000 pagore. HCC ndiyo inonyanya kufarirwa kenza yechiropa inosanganisira 75% -85% yekese yekutanga kenza yechiropa 1 ine ruzhinji rwevarwere vakawanikwa vaine chirwere chisinga gadziriswe. Colorectal cancer (CRC) ndiyo yechitatu inonyanya kuongororwa cancer2, inenge 22% yeCRCs iripo semCRC pakuongororwa kwekutanga, uye vanenge 70% yevarwere vanozopedzisira vaita metastatic relapse.3

Mike Mangano, Mutungamiriri uye CEO weABK Biomedical, akati, "Tinofara kuti kushanda kwedu kwekliniki naDkt Andrew Holden uye Auckland Hospital, NZ, kwasvika pachiitiko ichi chinokosha. Isu tinotenda kuti Eye90 microspheres ine mukana wekusimudzira Y90 radioembolization therapy mune itsva nguva yekuvandudzwa kwemhedzisiro yevarwere. Kunyanya, isu tinotarisira kudzidza yakakosha tekinoroji kufambira mberi iyo Eye90 microspheres inopa pamusoro peyakajairwa Y90 radioembolization zvishandiso. Izvi zvinosanganisira chirongwa chepamusoro chekutumira chinobvumira kutonga kwachiremba, kuona tumor-yakanangana, uye kugona kwe x-ray-based imaging data yekugadziriswa kwepamusoro, CT-based, Eye90 microspheres precision dosimetry ™. Dr. Robert Abraham, Chief Medical Officer uye Co-founder weABK Biomedical vakati, "Yave iri rwendo runoshamisa kutora kambani kubva kune pfungwa kuenda kune murwere kurapwa. Tine shungu uye tine tarisiro nezveramangwana reABK neEye90 microspheres. "

Andrew Holden, MD, MBChB, FRANZCR, EBIR, ONZM, muongorori mukuru wezvidzidzo, akati, "Isu tinokudzwa kuva vekutanga kurapa varwere nekombiyuta iyi yepamusoro uye kutungamirira ichi chinokosha chekiriniki chidzidzo chekuongorora teknolojia itsva iyi. Kune huwandu huri kukura hwakaburitswa Y90 radioembolization zvidzidzo zvinoratidza kushanda kwekiriniki muvarwere vakasarudzwa zvakakodzera. Tine shungu yekuongorora kuti Eye90 microspheres sei, neayo hurongwa hwekuburitsa uye hunhu hwepamusoro hwekufungidzira hunogona kukanganisa Y90 mhedzisiro yekiriniki mukurapwa kwevarwere vane HCC uye mCRC mamota echiropa.